Four consecutive massive earnings beats averaging over 265% above consensus demonstrate consistent under-promising and over-delivering, but this favorable earnings dynamic coexists with operating margin compression of 65.5%, quality metrics below the investment floor, and virtually no remaining near-term price upside—making the current entry point unattractive despite the strong beat streak.
Thesis pillars
- Quality Below Floor Value Trap↑Improving
- Piotroski Strength Amid Margin Pressure→Stable
- Massive Earnings Beat Streak↑Improving
- +1 more pillar — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Sep 9, 2026
InnovAge Holding Corp. (INNV) Stock Analysis
Range Bound setup
Healthcare · Medical Care Facilities
Sell if holding. Engine safety override at $9.10: Quality below floor (3.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.7/10 and A.R:R 1.8:1 is above the 1.5:1 BUY gate. Specifically: Elevated put/call ratio: 3.25; Below-average business quality.
InnovAge runs the Program of All-Inclusive Care for the Elderly (PACE), serving frail, largely dual-eligible seniors through 20 centers in six states with about 8,230 participants. It is paid fixed per-member, per-month capitation directly by Medicare and Medicaid and bears 100%... Read more
Sell if holding. Engine safety override at $9.10: Quality below floor (3.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.7/10 and A.R:R 1.8:1 is above the 1.5:1 BUY gate. Specifically: Elevated put/call ratio: 3.25; Below-average business quality. Chart setup: RSI 50 mid-range, Bollinger mid-band. Score 5.7/10, moderate confidence.
Passes 6/9 gates (positive momentum, favorable risk/reward ratio, no SEC red flags, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on clean insider activity and earnings proximity 5d<=7d. Suitability: aggressive.
About InnovAge Holding Corp.
About InnovAge Holding Corp.
InnovAge served approximately 8,230 PACE participants through 20 centers across California, Colorado, Florida, New Mexico, Pennsylvania and Virginia as of June 30, 2026, making it the largest PACE provider in the United States by participants served. The Denver, Colorado company manages its business as one reportable segment and describes itself as 19% larger than its closest PACE-focused competitor. Its participants carry an average Medicare Risk Adjustment Factor score of 2.48.
InnovAge contracts directly with Medicare and Medicaid on a per member, per month basis and receives 100% of the pooled capitated payment, which means the company is at risk for 100% of the healthcare costs of its participants. Capitation also comes from Medicare Parts C and D, the Veterans Administration and private pay, while the Centers for Medicare and Medicaid Services share part of the risk on prescription drugs. Care is delivered through interdisciplinary teams, care centers, in-home services and virtual visits, with transportation and meals included. Management estimates an annual revenue opportunity of $124,000 per participant, or $10,300 per month. Growth plans include de novo centers in Tampa and Orlando, Florida, run through joint ventures with Orlando Health and Tampa General Hospital. Competitors for participants and staff include hospitals, other PACE organizations, skilled nursing facilities and Medicare Advantage plans.
Show full overview
Payer mix and state policy form the sharpest exposure. A majority of capitation revenue comes from a limited number of government payors, particularly Medicare and Medicaid, concentrated in Colorado and California, so funding changes in those two states may weigh heavily on results. The Reconciliation Act signed on July 4, 2025 mandates reductions in federal Medicaid spending, and reductions to the Medicaid portion of PACE capitation rates could pressure revenue per enrollee. California adopted a pause on new PACE applications and service-area expansions from November 20, 2025 through November 19, 2027, which constrains new centers there, and the state previously suspended required attestations for the Bakersfield center. Principal Shareholders affiliated with Apax Partners and Welsh, Carson, Anderson & Stowe own approximately 82% of the common stock.
See also: Healthcare · Medical Care Facilities
From InnovAge Holding Corp.'s most recent 10-K filing, extracted October 18, 2026.
Recent developments
updated 2026-10-29Recent Developments — InnovAge Holding Corp.
Latest news
- NEWS InnovAge (NASDAQ:INNV) Issues Earnings Results - MarketBeat — MarketBeat neutral
- NEWS InnovAge (INNV) to Release Quarterly Earnings on Tuesday - MarketBeat — MarketBeat neutral
- NEWS Earnings call transcript: InnovAge Q3 2026 sees revenue growth, stock rise - Investing.com — Investing.com positive
- NEWS Earnings call transcript: InnovAge Q3 2026 sees revenue growth, stock rise - Investing.com Canada — Investing.com Canada positive
- NEWS InnovAge Holding Corp. (INNV) Reports Q3 Loss, Beats Revenue Estimates - Yahoo! Finance Canada — Yahoo! Finance Canada positive
Generated 2026-10-29T12:43:34Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMCustomerMedicare and Medicaid government payors10-K Item 1A: 'A majority of our capitation revenue is derived from a limited number of government payors, particularly Medicare and Medicaid, concentrated in Colorado and California'
- MEDIUMGeographicColorado and California10-K Item 1A: 'particularly Medicare and Medicaid, concentrated in Colorado and California'
- HIGHProductPACE program10-K Item 1A: 'We receive nearly all of our revenue through the PACE program'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Unprofitable operations — net margin -0.3%. Quality floor flags this regardless of sector context.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $9.10: Quality below floor (3.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.7/10 and A.R:R 1.8:1 is above the 1.5:1 BUY gate. Specifically: Elevated put/call ratio: 3.25; Below-average business quality. Chart setup: RSI 50 mid-range, Bollinger mid-band. Prior stop was $8.48. Score 5.7/10, moderate confidence.
Analyst target: $10.20 (+12.1% upside). Prior stop was $8.48. Stop-loss: $8.48.
Concentration risk — Product: PACE program; Quality below floor (3.9 < 4.0); Value-trap signals (2/5): Revenue declining (-7.6% YoY), Margin compression (op margin -0.3%).
InnovAge Holding Corp. trades at a P/E of N/A (forward 18.2). TrendMatrix value score: 7.0/10. Verdict: Sell.
8 analysts cover INNV with a consensus score of 2.4/5. Average price target: $12.
What does InnovAge Holding Corp. do?InnovAge runs the Program of All-Inclusive Care for the Elderly (PACE), serving frail, largely dual-eligible seniors...
InnovAge runs the Program of All-Inclusive Care for the Elderly (PACE), serving frail, largely dual-eligible seniors through 20 centers in six states with about 8,230 participants. It is paid fixed per-member, per-month capitation directly by Medicare and Medicaid and bears 100% of participants' care costs. Item 1 cites scale as the largest PACE provider by participants served.